Vaxcyte files patent for immunogenic composition for inducing immune responses against gas infections
Pharmaceutical Technology
DECEMBER 21, 2023
This innovative composition induces a protective immune response against Group A Streptococcus (GAS) bacteria, offering potential targets for vaccine development. Discover a groundbreaking immunogenic composition patent that combines GAS polypeptide antigens and polypeptide-polysaccharide conjugates.
Let's personalize your content